{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T05:33:39Z","timestamp":1773725619534,"version":"3.50.1"},"reference-count":46,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPR"],"DOI":"10.2147\/jpr.s393539","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T07:52:00Z","timestamp":1675237920000},"page":"327-339","source":"Crossref","is-referenced-by-count":1,"title":["Best Practices from the American Society of Pain and Neuroscience (ASPN) for Clinical Research During a Pandemic or Emergency"],"prefix":"10.2147","volume":"Volume 16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8548-1450","authenticated-orcid":true,"given":"Erika A","family":"Petersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8907-7730","authenticated-orcid":true,"given":"Timothy R","family":"Deer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stana","family":"Bojanic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren R","family":"Sankary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9489-2550","authenticated-orcid":true,"given":"Natalie H","family":"Strand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Al Kaisy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Huygen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8867-2140","authenticated-orcid":true,"given":"Dawood","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0812-5089","authenticated-orcid":true,"given":"Monique","family":"Steegers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verrills","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1019-0413","authenticated-orcid":true,"given":"Michael E","family":"Schatman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e182969","DOI":"10.1001\/jamanetworkopen.2018.2969","volume":"1","author":"Anderson","year":"2018","journal-title":"JAMA Netw Open"},{"key":"ref2","unstructured":"Fidelity Charitable. The role of volunteering in philanthropy. Available from: https:\/\/www.fidelitycharitable.org\/insights\/the-role-of-volunteering-in-philanthropy.html. Accessed April 8, 2021."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13063-020-05004-8","volume":"22","author":"Shiely","year":"2021","journal-title":"Trials"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.2147\/JPR.S295502","volume":"14","author":"Eshraghi","year":"2021","journal-title":"JPR"},{"key":"ref5","unstructured":"World Health Organization. Recommended format for a \u201cresearch protocol\u201d. Available from: https:\/\/www.who.int\/groups\/global-network-of-who-collaborating-centres-for-bioethics\/about\/research-ethics-review-committee. Accessed February 15, 2021."},{"key":"ref6","unstructured":"Children\u2019s Hospital of Philadelphia Research Institute. Writing a protocol. Available from: https:\/\/irb.research.chop.edu\/writing-protocol. Accessed February 15, 2021."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"Chan","year":"2013","journal-title":"Ann Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/1740774509102560","volume":"6","author":"Rosa","year":"2009","journal-title":"Clin Trials"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. J Am Med Assoc. 2013;310(20):2161\u20132194. doi:10.1001\/jama.2013.281053","DOI":"10.1001\/jama.2013.281053"},{"key":"ref10","unstructured":"IDE Institutional Review Boards (IRB). U.S. Food and Drug Administration; 2019. Available from: https:\/\/www.fda.gov\/medical-devices\/investigational-device-exemption-ide\/ide-institutional-review-boards-irb. Accessed February 15, 2021."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4097\/kjae.2012.62.1.3","volume":"62","author":"Kim","year":"2012","journal-title":"Korean J Anesthesiol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.soncn.2008.08.006","volume":"24","author":"Baquet","year":"2008","journal-title":"Semin Oncol Nurs"},{"key":"ref13","unstructured":"Guideline for good clinical practice - ICH harmonised tripartite guideline; 2002. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-e6-r1-guideline-good-clinical-practice_en.pdf. Accessed February 15, 2021."},{"key":"ref14","unstructured":"International Organization for Standardization. ISO 14155:2011 - Clinical investigation of medical devices for human subjects \u2014 good clinical practice. ISO 14155: Available from: https:\/\/www.iso.org\/standard\/45557.html. Accessed January 20, 2023."},{"key":"ref15","unstructured":"Directive 2010\/63\/EU of the European Parliament and of the Council of 22  September 2010 on the protection of animals used for scientific purposes text with EEA relevance. Vol OJ L.; 2010. Available from: http:\/\/data.europa.eu\/eli\/dir\/2010\/63\/oj\/eng. Accessed February 15, 2021."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4103\/ijp.IJP_310_20","volume":"52","author":"Mahalmani","year":"2020","journal-title":"Indian J Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0140-6736(20)31787-6","volume":"396","author":"van Dorn","year":"2020","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1213\/ANE.0000000000005000","volume":"131","author":"Deer","year":"2020","journal-title":"Anesth Analg"},{"key":"ref19","unstructured":"Food and Drug Administration. Conduct of clinical trials of medical products during the COVID-19 public health emergency guidance for industry, investigators, and institutional review boards; 2021. Available from: https:\/\/www.fda.gov\/media\/136238\/download. Accessed March 18, 2021."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s43018-020-0074-y","volume":"1","author":"Richards","year":"2020","journal-title":"Nat Cancer"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/virtualmentor.2010.12.9.ccas1-1009","volume":"12","author":"Daugherty","year":"2010","journal-title":"AMA J Ethics"},{"key":"ref22","unstructured":"The Belmont report: ethical principles and guidelines for the protection of human subjects of research; 1979. Available from: https:\/\/www.hhs.gov\/ohrp\/sites\/default\/files\/the-belmont-report-508c_FINAL.pdf. Accessed January 20, 2021."},{"key":"ref23","unstructured":"45 CFR 46: protection of human subjects; 2009. Available from: https:\/\/www.govinfo.gov\/content\/pkg\/CFR-2016-title45-vol1\/pdf\/CFR-2016-title45-vol1-part46.pdf. Accessed April 8, 2021."},{"key":"ref24","volume-title":"Principles of Biomedical Ethics","year":"2013"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1046\/j.1526-4637.2001.002002138.x","volume":"2","author":"Casarett","year":"2001","journal-title":"Pain Med"},{"key":"ref26","volume-title":"The Oxford Textbook of Clinical Research Ethics","year":"2011"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/tbm\/ibaa074","volume":"10","author":"Coleman","year":"2020","journal-title":"Transl Behav Med"},{"key":"ref28","unstructured":"National Institute for Health Research. DHSC issues guidance on the impact of COVID-19 on research funded or supported by NIHR; 2020. Available from: https:\/\/www.nihr.ac.uk\/news\/dhsc-issues-guidance-on-The-impact-on-covid-19-on-research-funded-or-supported-by-nihr\/24469. Accessed January 2, 2020."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"669","DOI":"10.47102\/annals-acadmedsg.2020130","volume":"49","author":"Chan","year":"2020","journal-title":"Ann Acad Med Singap"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1001\/jamaoncol.2020.5748","volume":"7","author":"Fluery","year":"2020","journal-title":"JAMA Oncol"},{"key":"ref31","unstructured":"The impact of COVID-19 on clinical trial sites: the results of a global survey performed by Medidata; 2020. Available from: https:\/\/www.medidata.com\/wp-content\/uploads\/2020\/05\/COVID19-Site-Survey_20200518_v1.pdf. Accessed May 31, 2020."},{"key":"ref32","unstructured":"Medicines and Healthcare products Regulatory Agency. Managing clinical trials during Coronavirus (COVID-19). Available from: https:\/\/www.gov.uk\/guidance\/managing-clinical-trials-during-coronavirus-covid-19. Accessed January 20, 2023.; 2020."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1748-720X.2009.00351.x","volume":"37","author":"Tait","year":"2009","journal-title":"J Law Med Ethics"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.2147\/JPR.S285835","volume":"13","author":"Schatman","year":"2020","journal-title":"J Pain Res"},{"key":"ref35","unstructured":"Kipnis K. Vulnerability in research subjects: a bioethical taxonomy; 2021. Available from: https:\/\/aapcho.org\/wp\/wp-content\/uploads\/2012\/02\/Kipnis-VulnerabilityinResearchSubjects.pdf. Accessed February 19, 2021."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.2147\/JPR.S264761","volume":"13","author":"Shapiro","year":"2020","journal-title":"J Pain Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/jama.2020.9286","volume":"324","author":"Fleming","year":"2020","journal-title":"JAMA"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1001\/jama.2020.8115","volume":"323","author":"Bauchner","year":"2020","journal-title":"JAMA"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1001\/jama.2020.4689","volume":"323","author":"McDermott","year":"2020","journal-title":"JAMA"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"113","DOI":"10.7326\/0003-4819-154-2-201101180-00010","volume":"154","author":"Fleming","year":"2011","journal-title":"Ann Intern Med"},{"key":"ref41","unstructured":"European Medicines Agency. Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic; 2020. Available from: https:\/\/www.ema.europa.eu\/en\/news\/guidance-sponsors-how-manage-clinical-trials-during-covid-19-pandemic. Accessed January 20, 2023."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1177\/1740774509347398","volume":"6","author":"Brosteanu","year":"2009","journal-title":"Clin Trials"},{"key":"ref43","unstructured":"Restart framework; 2020. Available from: https:\/\/www.nihr.ac.uk\/documents\/restart-framework\/24886. Accessed January 20, 2023."},{"key":"ref44","unstructured":"Guideline on missing data in confirmatory clinical trials; 2010. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-missing-data-confirmatory-clinical-trials_en.pdf. Accessed January 20, 2023."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1186\/s13063-020-04711-6","volume":"21","author":"Mitchell","year":"2020","journal-title":"Trials"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Nature Medicine. Safeguard research in the time of COVID-19. Nat Med. 2020;26(443). doi:10.1038\/s41591-020-0852-1","DOI":"10.1038\/s41591-020-0852-1"}],"container-title":["Journal of Pain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=87212","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=87212","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T07:52:26Z","timestamp":1675237946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/best-practices-from-the-american-society-of-pain-and-neuroscience-aspn-peer-reviewed-fulltext-article-JPR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":46,"URL":"https:\/\/doi.org\/10.2147\/jpr.s393539","relation":{},"ISSN":["1178-7090"],"issn-type":[{"value":"1178-7090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2]]}}}